These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27293058)

  • 41. miR-4443 Participates in the Malignancy of Breast Cancer.
    Chen X; Zhong SL; Lu P; Wang DD; Zhou SY; Yang SJ; Shen HY; Zhang L; Zhang XH; Zhao JH; Tang JH
    PLoS One; 2016; 11(8):e0160780. PubMed ID: 27504971
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Significance of miR-148a in Colorectal Neoplasia: Downregulation of miR-148a Contributes to the Carcinogenesis and Cell Invasion of Colorectal Cancer.
    Hibino Y; Sakamoto N; Naito Y; Goto K; Oo HZ; Sentani K; Hinoi T; Ohdan H; Oue N; Yasui W
    Pathobiology; 2015; 82(5):233-41. PubMed ID: 26389729
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
    Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
    Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.
    Yan LX; Huang XF; Shao Q; Huang MY; Deng L; Wu QL; Zeng YX; Shao JY
    RNA; 2008 Nov; 14(11):2348-60. PubMed ID: 18812439
    [TBL] [Abstract][Full Text] [Related]  

  • 45. miR-125a-5p expression is associated with the age of breast cancer patients.
    He H; Xu F; Huang W; Luo SY; Lin YT; Zhang GH; Du Q; Duan RH
    Genet Mol Res; 2015 Dec; 14(4):17927-33. PubMed ID: 26782438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.
    Shen Y; Ye YF; Ruan LW; Bao L; Wu MW; Zhou Y
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distinct pathways in the pathogenesis of sebaceous carcinomas implicated by differentially expressed microRNAs.
    Tetzlaff MT; Curry JL; Yin V; Pattanaprichakul P; Manonukul J; Uiprasertkul M; Manyam GC; Wani KM; Aldape K; Zhang L; Prieto VG; Esmaeli B
    JAMA Ophthalmol; 2015 Oct; 133(10):1109-16. PubMed ID: 26203913
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MiR-630 suppresses breast cancer progression by targeting metadherin.
    Zhou CX; Wang CL; Yu AL; Wang QY; Zhan MN; Tang J; Gong XF; Yin QQ; He M; He JR; Chen GQ; Zhao Q
    Oncotarget; 2016 Jan; 7(2):1288-99. PubMed ID: 26595523
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
    Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
    Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression Analysis of MicroRNA-222 in Breast Cancer.
    Amini S; Abak A; Estiar MA; Montazeri V; Abhari A; Sakhinia E
    Clin Lab; 2018 Apr; 64(4):491-496. PubMed ID: 29739090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Study on the relationship between miR-520g and the development of breast cancer.
    Ren GB; Wang L; Zhang FH; Meng XR; Mao ZP
    Eur Rev Med Pharmacol Sci; 2016; 20(4):657-63. PubMed ID: 26957267
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Abnormal miRNA-30e Expression is Associated with Breast Cancer Progression.
    Lin Z; Li JW; Wang Y; Chen T; Ren N; Yang L; Xu W; He H; Jiang Y; Chen X; Liu T; Liu G
    Clin Lab; 2016; 62(1-2):121-8. PubMed ID: 27012041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aberrant expression of miR-9 in benign and malignant breast tumors.
    Hasanzadeh A; Mesrian Tanha H; Ghaedi K; Madani M
    Mol Cell Probes; 2016 Oct; 30(5):279-284. PubMed ID: 27725294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between mir-24 and mir-378 in formalin-fixed paraffin-embedded tissues of breast cancer.
    Yin JY; Deng ZQ; Liu FQ; Qian J; Lin J; Tang Q; Wen XM; Zhou JD; Zhang YY; Zhu XW
    Int J Clin Exp Pathol; 2014; 7(7):4261-7. PubMed ID: 25120807
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miR-10b, miR-26a, miR-146a And miR-153 Expression in Triple Negative Vs Non Triple Negative Breast Cancer: Potential Biomarkers.
    Fkih M'hamed I; Privat M; Trimeche M; Penault-Llorca F; Bignon YJ; Kenani A
    Pathol Oncol Res; 2017 Oct; 23(4):815-827. PubMed ID: 28101798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Computational Identification of Sex-Biased Biomarker MicroRNAs and Genes Associated with Immune Infiltration in Breast Cancer.
    Li EW; Bai Y
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33919884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of MiR-21 and MiR-10b Expression of Human Breast Cancer in West Sumatera.
    Yanwirasti ; A Harahap W; Arisanty D
    Pak J Biol Sci; 2017; 20(4):189-196. PubMed ID: 29023075
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression Levels of MMP9 and PIWIL2 in Prostate Cancer: a Case-Control Study.
    Pouyanfar N; Monabbati A; Sharifi AA; Dianatpour M
    Clin Lab; 2016; 62(4):651-7. PubMed ID: 27215085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potential diagnostic implications of miR-144 overexpression in human oesophageal cancer.
    Sharma P; Saraya A; Sharma R
    Indian J Med Res; 2016 May; 143(Supplement):S91-S103. PubMed ID: 27748283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients.
    Lánczky A; Nagy Á; Bottai G; Munkácsy G; Szabó A; Santarpia L; Győrffy B
    Breast Cancer Res Treat; 2016 Dec; 160(3):439-446. PubMed ID: 27744485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.